Review





Similar Products

99
Enamine Ltd remdesivir
Remdesivir, supplied by Enamine Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/remdesivir/Remdesivir/custom%40en300-22849306%4010%2E1007%2Fs11696-026-05326-y
Average 99 stars, based on 1 article reviews
remdesivir - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

96
MedChemExpress gs 5734
Gs 5734, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/remdesivir/Remdesivir/bio_rxiv__64898__2026__06__12__731861-75-18-19
Average 96 stars, based on 1 article reviews
gs 5734 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
MedChemExpress remdesivir
Remdesivir, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/remdesivir/Remdesivir/custom%40hy-104077%4042074328
Average 96 stars, based on 1 article reviews
remdesivir - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
MedChemExpress hy 104077
Hy 104077, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/remdesivir/Remdesivir/pmc13101006-63-4-3
Average 96 stars, based on 1 article reviews
hy 104077 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

99
Gilead Sciences remdesivir nucleoside
Remdesivir Nucleoside, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/remdesivir/VEKLURY/us12594292-874-194-194
Average 99 stars, based on 1 article reviews
remdesivir nucleoside - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

96
MedChemExpress lopinavir
PHEV dsRNA serves as a prerequisite for RIG-I-dependent induction of type I IFN. ( A ) Schematic illustration of the proposed mechanisms by which Remdesivir (RDV) and <t>Lopinavir</t> (LPV) suppress PHEV replication. RdRp, RNA-dependent RNA polymerase; 3CLpro, 3C-like protease. ( B ) RDV and LPV suppress PHEV replication. N2a cells were infected with PHEV for 1 h, treated with RDV or LPV (20 μM), and harvested at 24 h post-infection for qRT-PCR analysis of PHEV mRNA levels. ( C ) QRT-PCR analysis of IFNA and IFNB1 mRNA expression as described in panel B . ( D ) QRT-PCR analysis of I RIG-I, IRF3, and IRF7 mRNA expression as described in panel B . ( E ) WB analysis of RIG-I, phosphorylated IRF3 (p-IRF3), p-IRF7, and PHEV N protein as described in panel B . ( F ) Immunostaining assay. N2a cells as indicated in panel B were harvested and immunostained with anti-dsRNA (red) and anti-RIG-I (green) antibodies, DAPI (blue). Scale bar, 10 µm. Data represent mean ± SD (** P < 0.01 and *** P < 0.001 by unpaired two-tailed Student’s t-test).
Lopinavir, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/remdesivir/Remdesivir/pmc13098281-128-3-7
Average 96 stars, based on 1 article reviews
lopinavir - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

96
MedChemExpress hy
PHEV dsRNA serves as a prerequisite for RIG-I-dependent induction of type I IFN. ( A ) Schematic illustration of the proposed mechanisms by which Remdesivir (RDV) and <t>Lopinavir</t> (LPV) suppress PHEV replication. RdRp, RNA-dependent RNA polymerase; 3CLpro, 3C-like protease. ( B ) RDV and LPV suppress PHEV replication. N2a cells were infected with PHEV for 1 h, treated with RDV or LPV (20 μM), and harvested at 24 h post-infection for qRT-PCR analysis of PHEV mRNA levels. ( C ) QRT-PCR analysis of IFNA and IFNB1 mRNA expression as described in panel B . ( D ) QRT-PCR analysis of I RIG-I, IRF3, and IRF7 mRNA expression as described in panel B . ( E ) WB analysis of RIG-I, phosphorylated IRF3 (p-IRF3), p-IRF7, and PHEV N protein as described in panel B . ( F ) Immunostaining assay. N2a cells as indicated in panel B were harvested and immunostained with anti-dsRNA (red) and anti-RIG-I (green) antibodies, DAPI (blue). Scale bar, 10 µm. Data represent mean ± SD (** P < 0.01 and *** P < 0.001 by unpaired two-tailed Student’s t-test).
Hy, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/remdesivir/Remdesivir/pmc13107972-23-6-3
Average 96 stars, based on 1 article reviews
hy - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


PHEV dsRNA serves as a prerequisite for RIG-I-dependent induction of type I IFN. ( A ) Schematic illustration of the proposed mechanisms by which Remdesivir (RDV) and Lopinavir (LPV) suppress PHEV replication. RdRp, RNA-dependent RNA polymerase; 3CLpro, 3C-like protease. ( B ) RDV and LPV suppress PHEV replication. N2a cells were infected with PHEV for 1 h, treated with RDV or LPV (20 μM), and harvested at 24 h post-infection for qRT-PCR analysis of PHEV mRNA levels. ( C ) QRT-PCR analysis of IFNA and IFNB1 mRNA expression as described in panel B . ( D ) QRT-PCR analysis of I RIG-I, IRF3, and IRF7 mRNA expression as described in panel B . ( E ) WB analysis of RIG-I, phosphorylated IRF3 (p-IRF3), p-IRF7, and PHEV N protein as described in panel B . ( F ) Immunostaining assay. N2a cells as indicated in panel B were harvested and immunostained with anti-dsRNA (red) and anti-RIG-I (green) antibodies, DAPI (blue). Scale bar, 10 µm. Data represent mean ± SD (** P < 0.01 and *** P < 0.001 by unpaired two-tailed Student’s t-test).

Journal: Journal of Virology

Article Title: Porcine hemagglutinating encephalomyelitis virus nucleocapsid protein targets RIG-I and IRF3 to evade IFN immunity

doi: 10.1128/jvi.02112-25

Figure Lengend Snippet: PHEV dsRNA serves as a prerequisite for RIG-I-dependent induction of type I IFN. ( A ) Schematic illustration of the proposed mechanisms by which Remdesivir (RDV) and Lopinavir (LPV) suppress PHEV replication. RdRp, RNA-dependent RNA polymerase; 3CLpro, 3C-like protease. ( B ) RDV and LPV suppress PHEV replication. N2a cells were infected with PHEV for 1 h, treated with RDV or LPV (20 μM), and harvested at 24 h post-infection for qRT-PCR analysis of PHEV mRNA levels. ( C ) QRT-PCR analysis of IFNA and IFNB1 mRNA expression as described in panel B . ( D ) QRT-PCR analysis of I RIG-I, IRF3, and IRF7 mRNA expression as described in panel B . ( E ) WB analysis of RIG-I, phosphorylated IRF3 (p-IRF3), p-IRF7, and PHEV N protein as described in panel B . ( F ) Immunostaining assay. N2a cells as indicated in panel B were harvested and immunostained with anti-dsRNA (red) and anti-RIG-I (green) antibodies, DAPI (blue). Scale bar, 10 µm. Data represent mean ± SD (** P < 0.01 and *** P < 0.001 by unpaired two-tailed Student’s t-test).

Article Snippet: The Remdesivir and Lopinavir were purchased from MCE.

Techniques: Infection, Quantitative RT-PCR, Expressing, Immunostaining, Two Tailed Test